Nice simple logic.... what is lacking for so many who are emotionally invested in the "what ifs". Any tiny remaining doubt for me regarding this pony and dog show, was squashed when I did my DD on Dr. Emmanuel O. Fadrian who is now with Anavex as their FDA get the drug to market guy. His bio with Anavex is STELLAR. Then you go to Bloomberg Bio for him and find his BS and MS degrees were earned from a Nigerian university, and he is currently a pharmacist working for Rite Aid in a seedy Baltimore area and active with Groupon for toiletry specials. Can't make this chit up! That is a rather different picture than Anavex painted with their bio of the good Doctor Fadrian. Read THAT bio, and this guy sounds like he was one rung below God in the FDA. Add to that, the MANY far away scientists whose names were dropped in releases as attached to this company smacks of "too far away to be able to do proper DD" Over the last year, i have also found numerous brand new investor news web sites which appear out of no where to tout this company. Add the CEOs constant stream of $1500 stock buys to trigger the insider purchase free PR's. THAT smacks of manipulation to prop up stock price. Name me ONE other CEO anywhere in the markets who does the same tiny buys for PR value! Just ONE! You can't. The truth doesn't care who speaks it. Old adage of a sucker born every day applies here in spades once you do your DD, and look at this unemotionally with simple logic. "If it's too good to be true...." This whole thing feels like I walked onto a tiny used car lot which specializes in bottom of the market transportation cars. Bottom line is my opinion is this company will NEVER bring a drug to market. It will be the same as previous NINE years...a never ending series of PR releases, some of which sound like they are SO CLOSE to phase 2/3, but never quite seem to get there. Now the focus is back to Parkinsons....last month it was Rhetts, month before that was AD...yaaaawn
AI
Market Data 
Markets 
